Dr. Waxman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-615-5858- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 2011 - 2014
Duke University School of MedicineClass of 2011
Certifications & Licensure
PA State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsProgressive multifocal leukoencephalopathy in multiple myeloma.Brian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman, Mark Bardsley, Samantha Le, Lexis LaMaestra, Alfred L Garfall> ;European Journal of Haematology. 2023 Mar 1
- 14 citationsAnti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gup...> ;Blood Cancer Discovery. 2023 Mar 1
- Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma TherapyAlfred L. Garfall, Adam B. Cohen, Edward A. Stadtmauer, Sandra Susanibar-Adaniya, Dan T. Vogl, Adam Waxman> ;Journal of Clinical Oncology. 2021 Oct 15
- Join now to see all
Abstracts/Posters
- Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple MyelomaAdam Waxman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Proteasome inhibitor associated cardiovascular adverse events: A real-world claims based study.2019 ASCO Annual Meeting - 6/1/2019
- PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
OncLive® Presents State of the Science Summit™ on the Treatment of Hematologic MalignanciesSeptember 10th, 2019
Cardiovascular Toxicity and Carfilzomib Treatment in Multiple MyelomaApril 10th, 2018
Carfilzomib Can Lead to Cardiovascular Toxicity in Multiple Myeloma PatientsJanuary 20th, 2018- Join now to see all
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
